Belatacept/CTLA4Ig: an update and critical appraisal of preclinical and clinical results
Sign Up to like & getrecommendations! Published in 2018 at "Expert Review of Clinical Immunology"
DOI: 10.1080/1744666x.2018.1485489
Abstract: ABSTRACT Introduction: The B7/CD28/CTLA4 signaling cascade is the most thoroughly studied costimulatory pathway and blockade with CTLA4Ig (abatacept) or its derivative belatacept has emerged as a valuable option for pharmacologic immune modulation. Several clinical studies… read more here.
Keywords: ctla4ig update; clinical results; belatacept ctla4ig; update critical ... See more keywords